- Pivot Pharma enters US CBD market with its proprietary CBD product line
- PIVOT responds to Stockwatch Article on Notice of Claim filed by Aly Ismail
- Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing
- Pivot Pharmaceuticals Inc. to Webcast Live at VirtualInvestorConferences.com September 12th
- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th
- Pivot Pharma enters into binding Letter of Intent to acquire a controlling interest in iAmHealth CBD UG, an online nutraceutical sales platform serving Europe
Pivot Pharmaceuticals Inc (NPAT:FRA) closed at 0.0755, 5.59% above its 52-week low of 0.0715, set on Nov 11, 2019.
0.0715Nov 11 20190.33Jul 01 2019
Markit short selling activity
|Market cap||22.24m CAD|
Data delayed at least 15 minutes, as of Nov 15 2019 17:28 GMT.